Open AccessPossible agent for COVID-19 treatment: Rifampicin
Author(s) -
Özlem Çelik Aydın,
Sonay Aydın,
Süreyya Barun
Publication year - 2022
Publication title -
world journal of virology
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2220-3249
DOI - 10.5501/wjv.v11.i5.391
Subject(s) - rifampicin , in silico , covid-19 , medicine , intensive care medicine , drug , coronavirus , drug treatment , pharmacology , virology , disease , tuberculosis , pathology , infectious disease (medical specialty) , biology , biochemistry , outbreak , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom